Page 10 - Compass

Bata India stares at earnings downgrades

Weak show for a consecutive quarter and high-value note ban will weigh on the stock

Correction a good opportunity to buy engineering stocks

ABB, Siemens, Cummins, and Bhel offer potential

Near term growth concerns to weigh on Sun Pharma

Regulatory clearances remain crucial for US growth

Robust India show boost Cipla's Q2

Company maintains operating-profit margin forecast at 16-18 per cent for FY17

Lupin: An outlier in the pharma pack

New product launches will drive US growth, local sales will be driven by expanded field force

Novelis booster for Hindalco

Improving profits of Novelis, India operations, and debt reduction, will drive Hindalco's stock valuation

Sluggish CV sales weigh on Bharat Forge's Q2 performance

A better performance in the second half of this financial year could have a positive impact on the stock

Margin pressures ahead for Amara Raja Batteries

Results in line with estimates, but rise in lead prices and competition could weigh on profit

ICICI Bank: Clarity on NPA resolution needed for more re-rating

Bank made good of gains from ICICI Prudential Life stake sale, Q2 results in line with estimates

Near-term pressures for Dish TV

Muted September quarter additions and Arpu pressures are an overhang

Adani Ports: More room for rerating

Earnings are rising and concerns on related-party loans are being addressed effectively

Improvement in Q1 raises hope for JSPL

Expected turnaround in power business to boost prospects further

Hero MotoCorp: Lower raw material costs boost margins

The company is looking at maintaining margins while protecting its market share

Sun Pharma buoyed by success of new products

However, near-term prospects hinge on base business performance and growth guidance